WR-238605
| Title | Journal |
|---|---|
| Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. | Lancet (London, England) 20140322 |
| Uptake of the antileishmania drug tafenoquine follows a sterol-dependent diffusion process in Leishmania. | The Journal of antimicrobial chemotherapy 20111101 |
| Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection. | Bioanalysis 20110801 |
| Enantiomeric separation of antimalarial drugs by capillary electrophoresis using neutral and negatively charged cyclodextrins. | Journal of pharmaceutical and biomedical analysis 20110220 |
| Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta). | Malaria journal 20110101 |
| Primaquine in vivax malaria: an update and review on management issues. | Malaria journal 20110101 |
| Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children before and after artemisinin-based combination treatments. | Chemotherapy 20110101 |
| Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine. | Antimicrobial agents and chemotherapy 20101201 |
| A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers. | The American journal of tropical medicine and hygiene 20090801 |
| The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific. | Transactions of the Royal Society of Tropical Medicine and Hygiene 20081101 |
| Tafenoquine: a promising new antimalarial agent. | Expert opinion on investigational drugs 20070501 |
| Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis. | Transactions of the Royal Society of Tropical Medicine and Hygiene 20070301 |
| Tafenoquine for the treatment of recurrent Plasmodium vivax malaria. | The American journal of tropical medicine and hygiene 20070301 |
| Treatment of acute vivax malaria with tafenoquine. | Transactions of the Royal Society of Tropical Medicine and Hygiene 20050101 |
| Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria. | The Journal of infectious diseases 20041015 |
| Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20041015 |
| Plasma concentrations of tafenoquine, a new long-acting antimalarial agent, in thai soldiers receiving monthly prophylaxis. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031215 |
| Military aviators, special operations forces, and causal malaria prophylaxis. | Military medicine 20031201 |
| New antimalarial drugs. | Angewandte Chemie (International ed. in English) 20031110 |
| Transmission-blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally circulating strains of Plasmodium vivax in Thailand. | The American journal of tropical medicine and hygiene 20031101 |
| Molecule of the month. Tafenoquine succinate. | Drug news & perspectives 20030501 |
| Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys. | Acta tropica 20030401 |
| The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines. | Annals of tropical medicine and parasitology 20030401 |
| A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030301 |
| In-vitro interaction of tafenoquine and chloroquine in Plasmodium falciparum from northwestern Thailand. | Wiener klinische Wochenschrift 20030101 |
| In vitro activity of tafenoquine alone and in combination with artemisinin against Plasmodium falciparum. | The American journal of tropical medicine and hygiene 20020701 |
| Rapid determination of tafenoquine in small volume human plasma samples by high-performance liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020325 |
| Comparison of tafenoquine (WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax malaria in Australian Defence Force personnel. | Transactions of the Royal Society of Tropical Medicine and Hygiene 20020101 |
| A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20011215 |
| Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers. | British journal of clinical pharmacology 20011201 |
| Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010801 |
| Malaria prophylaxis/radical cure: recent experiences of the Australian Defence Force. | Medecine tropicale : revue du Corps de sante colonial 20010101 |
| First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. | The American journal of tropical medicine and hygiene 19980501 |